
Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
Author(s) -
Zhiqin Zhang,
Lihua Ni,
Lian Zhang,
Dongqing Zha,
Chun Hu,
Lingli Zhang,
H. Amy Feng,
Xiaobao Wei,
Xiaoyan Wu
Publication year - 2021
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s289712
Subject(s) - empagliflozin , lipid metabolism , diabetic nephropathy , endocrinology , medicine , adiponectin receptor 1 , ampk , adiponectin , diabetes mellitus , chemistry , type 2 diabetes , insulin resistance , biochemistry , phosphorylation , protein kinase a